Fiyyaz Ahmed-Jushuf
Overview
Explore the profile of Fiyyaz Ahmed-Jushuf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hammond-Haley M, Chiew K, Ahmed-Jushuf F, Rajkumar C, Foley M, Simader F, et al.
EuroIntervention
. 2025 Jan;
21(1):46-57.
PMID: 39773830
Background: Microvascular angina (MVA) is an important contributor to morbidity and mortality in patients with non-obstructive coronary artery disease. Despite improvements in its recognition and diagnosis, uncertainty remains around the...
2.
Foley M, Rajkumar C, Ahmed-Jushuf F, Simader F, Chotai S, Seligman H, et al.
Circulation
. 2024 Oct;
151(3):202-214.
PMID: 39462291
Background: ORBITA-2 (the Placebo-Controlled Trial of Percutaneous Coronary Intervention for the Relief of Stable Angina) provided evidence for the role of percutaneous coronary intervention (PCI) for angina relief in stable...
3.
Ahmed-Jushuf F, Chotai S, Al-Lamee R
J Am Coll Cardiol
. 2024 Jul;
84(4):351-353.
PMID: 39019529
No abstract available.
4.
Simader F, Rajkumar C, Foley M, Ahmed-Jushuf F, Chotai S, Bual N, et al.
J Am Coll Cardiol
. 2024 May;
84(1):13-24.
PMID: 38759906
Background: Placebo-controlled evidence from ORBITA-2 (Objective Randomised Blinded Investigation with Optimal Medical Therapy of Angioplasty in Stable Angina-2) found that percutaneous coronary intervention (PCI) in stable coronary artery disease with...
5.
Rajkumar C, Foley M, Ahmed-Jushuf F, Simader F, Mohsin M, Ganesananthan S, et al.
J Am Coll Cardiol
. 2024 May;
84(1):1-12.
PMID: 38752902
Background: In stable coronary artery disease, 30% to 60% of patients remain symptomatic despite successful revascularization. Perhaps not all symptoms reported by a patient with myocardial ischemia are, in fact,...
6.
Rajkumar C, Thomas K, Foley M, Ganesananthan S, Evans H, Simader F, et al.
JAMA Surg
. 2024 Apr;
159(7):776-790.
PMID: 38630462
Importance: Unlike medications, procedural interventions are rarely trialed against placebo prior to becoming accepted in clinical practice. When placebo-controlled trials are eventually conducted, procedural interventions may be less effective than...
7.
Foley M, Rajkumar C, Ahmed-Jushuf F, Simader F, Chotai S, Pathimagaraj R, et al.
Lancet
. 2024 Apr;
403(10436):1543-1553.
PMID: 38604209
Background: The coronary sinus reducer (CSR) is proposed to reduce angina in patients with stable coronary artery disease by improving myocardial perfusion. We aimed to measure its efficacy, compared with...
8.
Foley M, Rajkumar C, Ahmed-Jushuf F, Nowbar A, Simader F, Bello O, et al.
Circ Cardiovasc Qual Outcomes
. 2024 Feb;
17(3):e010664.
PMID: 38362766
No abstract available.
9.
Foley M, Rajkumar C, Ahmed-Jushuf F, Simader F, Pathimagaraj R, Nijjer S, et al.
EuroIntervention
. 2024 Jan;
20(3):e216-e223.
PMID: 38214677
The coronary sinus Reducer (CSR) is an hourglass-shaped device which creates an artificial stenosis in the coronary sinus. Whilst placebo-controlled data show an improvement in angina, these results are unreplicated...
10.
Rajkumar C, Foley M, Ahmed-Jushuf F, Nowbar A, Simader F, Davies J, et al.
N Engl J Med
. 2023 Nov;
389(25):2319-2330.
PMID: 38015442
Background: Percutaneous coronary intervention (PCI) is frequently performed to reduce the symptoms of stable angina. Whether PCI relieves angina more than a placebo procedure in patients who are not receiving...